Xeris Biopharma Holdings, Inc. (XERS) Insider Ownership

Historic Insider Ownership Trends

XERS's three largest insider shareholders as of April 17, 2026 are Paul R Edick (Director, 3.79Mn shares), John Patrick Jr Shannon (Director, 2.94Mn shares), Kevin Mcculloch (Officer, 1.78Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Paul R Edick - 3,788,064 0 31 Jan, 2024
John Patrick Jr Shannon - 2,935,578 0 02 Feb, 2026
Kevin Mcculloch - 1,777,725 0 16 Mar, 2026
Steven Pieper - 1,408,940 0 05 Mar, 2026
Beth Hecht - 1,209,840 0 03 Apr, 2026
Steven Prestrelski Chief Scientific Officer 719,780 0 01 Feb, 2023
John Johnson - 698,083 0 19 Dec, 2025
Anh Tu Nguyen - 395,023 0 25 Feb, 2026
Kenneth Erland Johnson - 320,446 0 03 Feb, 2025
Jeffrey W Sherman - 219,188 0 29 Aug, 2025
Garheng Kong - 214,144 0 04 Jun, 2025
Barbara-Jean Anne Bormann-Kennedy - 142,500 0 15 Dec, 2025
Marla Persky - 142,000 0 12 Sep, 2025
Ricki Louise Fairley - 135,000 0 05 Jun, 2024
Dawn Halkuff - 115,000 0 13 Aug, 2025
John P. Schmid - 113,159 0 05 Jun, 2024
James Aloysius Brady - 89,166 0 01 Apr, 2026
Paul R Edick - 0 33,430 16 Nov, 2021
John P. Schmid - 0 25,200 13 Aug, 2024
Paul R Edick - 0 13,430 05 Oct, 2021
Marla Persky - 0 6,370 15 Nov, 2023
Dawn Halkuff - 0 5,410 21 Nov, 2023
Jeffrey W Sherman - 0 5,400 29 Nov, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Apr, 2026 Beth Hecht Common Stock D 16,667 $5.99 1,209,840 D S
30 Mar, 2026 James Aloysius Brady Common Stock D 10,834 $5.54 89,166 D S
12 Mar, 2026 Kevin Mcculloch Common Stock A 48,894 $4.09 1,777,721 D M
12 Mar, 2026 Kevin Mcculloch Common Stock A 4 $3.94 1,777,725 D M
12 Mar, 2026 Kevin Mcculloch Stock Option (Right to Buy) D 48,894 $4.09 43,773 D M
12 Mar, 2026 Kevin Mcculloch Stock Option (Right to Buy) D 4 $3.94 79,996 D M
05 Mar, 2026 Steven Pieper Common Stock A 27,891 $4.09 1,394,904 D M
05 Mar, 2026 Steven Pieper Common Stock A 14,036 $5.93 1,408,940 D M
05 Mar, 2026 Steven Pieper Stock Option (Right to Buy) D 27,891 $0.00 0 D M
05 Mar, 2026 Steven Pieper Stock Option (Right to Buy) D 14,036 $0.00 0 D M
02 Mar, 2026 Beth Hecht Common Stock D 16,567 $6.24 1,226,607 D S
02 Mar, 2026 Beth Hecht Common Stock D 100 $7.06 1,226,507 D S
24 Feb, 2026 Anh Tu Nguyen Common Stock D 29,300 $6.88 395,023 D F
30 Jan, 2026 Anh Tu Nguyen Common Stock A 121,293 $0.00 424,323 D A
30 Jan, 2026 Steven Pieper Common Stock A 154,986 $0.00 1,572,547 D A
30 Jan, 2026 Kevin Mcculloch Common Stock A 168,463 $0.00 1,853,889 D A
30 Jan, 2026 Beth Hecht Common Stock A 121,293 $0.00 1,429,396 D A
30 Jan, 2026 John Patrick Jr Shannon Common Stock A 478,436 $0.00 3,276,083 D A
31 Jan, 2026 Steven Pieper Common Stock D 111,765 $7.36 1,460,782 D F
31 Jan, 2026 Beth Hecht Common Stock D 98,375 $7.36 1,331,021 D F